For decades, scientists have thought they understood the biochemical machinery that causes asthma-inflammation in the lungs that constricts airways and makes it hard to breathe.

Dr. Innocent Clement, physician and CEO of Ciba Health, examines how technology is reshaping chronic care delivery. Dr.

CDR-Life, Inc., a biotechnology company developing highly selective T cell engagers (TCEs) to treat cancer and autoimmune diseases, today announced the first clinical data showing that CDR404, the ...

Albert Einstein College of Medicine has received a five-year, $10.8 million grant from the National Institutes of Health (NIH) to create the New York Regional Diabetes Research Center (NYR-DRC), a ...

The African Medicines Innovations and Technology Development Platform (AMITD) at the University of the Free State (UFS), under the leadership ...

Ferrari provided flights from Washington, DC, to Austin, Texas, and accommodation so Ars could attend the Lone Star Le Mans. Ars does not accept paid editorial content. The first time I drove this ...

Won received her Doctor of Pharmacy from University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, ...